AXS-05
Axsome Therapeutics Provides Update on the New Drug Application for AXS-05 for the Treatment of Major Depressive Disorder NEW YORK, Aug. 23, 2021 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company…
27 People Test Positive for COVID-19 on Carnival Cruise Ship Carrying Nearly 4,500
A spokesperson for Carnival told PEOPLE in a statement that they are "managing a small number of positive COVID cases on Carnival Vista sailing out of Galveston." "We have managed…
ganaxolone
ganaxolone Marinus Pharmaceuticals Submits New Drug Application (NDA) to FDA for Ganaxolone for the Treatment of Seizures Associated with CDKL5 Deficiency Disorder and Provides Pipeline Update RADNOR, Pa.–(BUSINESS WIRE)–August 3,…
tenapanor
tenapanor Ardelyx Receives Complete Response Letter from U.S. FDA for New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis FREMONT, Calif. and WALTHAM,…
Snake Bite Lands 5-Year-Old in the Hospital, and Now Mom is Warning Other Parents
A scary moment for one family has turned into a teachable moment for parents everywhere. Cyndi Spell recently spoke to TODAY Parents about why it's important to educate children about…
Experts Give these Effective Meditation Tips for First Timers!
One of the most efficient methods of harnessing your mental health is through meditation. We’ve heard the astounding benefits you get from meditating like clearing up your mind, improving your…
Experts Reveal How to Deal and Overcome Changes in Your Business and Life
If one thing is constant and consistent in our business and life, that’d be change. The business world is struggling in dealing with disruption especially since new businesses have emerged…
Tiny implant cures diabetes in mice without triggering immune response
A team of researchers led by diabetes specialists and biomedical engineers at Washington University School of Medicine in St. Louis and Cornell University has demonstrated that, using a miniscule device,…
bardoxolone
bardoxolone Reata Announces FDA Accepted for Filing the NDA for Bardoxolone for the Treatment of Patients With Chronic Kidney Disease Caused by Alport Syndrome PLANO, Texas, April 26, 2021 (GLOBE…
For malnourished children, a new type of microbiome-directed food boosts growth
A new type of therapeutic food specifically designed to repair the gut microbiomes of malnourished children is superior to standard therapy in promoting growth, according to the results of a…